Livermore researchers apply combat simulation technology to homelan...( tion to emergency response planning and...)

Livermore researchers apply combat simulation technology to homeland security

tion to emergency response planning and training. ACATS is one of many tools being developed for homeland security. The homeland security mission of the Lawrence Livermore National Laboratory is to support the Department of Homeland Security, and its government and private partners, in reducing the nation's vulnerability to terrorism, preventing terrorist attacks within the United States, and responding to and recovering from any attacks that do occur.

The Laboratory's extensive scientific and technical expertise will be utilized to provide solutions that integrate advanced technologies into operational realities. The Laboratory provides field-demonstrated prototypes, comprehensive threat, vulnerability and tradeoff analyses, and operational capabilities to defend against catastrophic terrorism, including nuclear, chemical, biological, cyber attacks and other threats that can cause mass destruction or disruption.

'"/>

Contact: Anne M. Stark
stark8@llnl.gov
925-422-9979
DOE/Lawrence Livermore National Laboratory
10-Dec-2002

Page: 1 2
Related biology news :

1. Livermore research in accelerator mass spectrometry highlighted at ACS meeting
2. Livermore & NIH scientists create technique to examine behavior of proteins at single molecule level
3. NNSAs Livermore Lab partners with cities and counties to track biological, chemical releases
4. Lawrence Livermore research team finds unique DNA signatures to improve anthrax detection
5. Livermore Lab hosts conference on Bioterrorism for the Courts
6. Livermore research team wins distinguished Department of Energy award for development of miniature glucose sensor for diabetes patients
7. Lawrence Livermore Lab, UC Davis Cancer Center ink alliance to develop integrated cancer program
8. UC Davis and Lawrence Livermore National Laboratory seek industry partners to develop new bio and medical technology products
9. Belgian researchers explore revolutionary approach to angiogenesis
10. Award winning researchers reveal potential new role for Glivec
11. $7.5 Million grant to Yale researchers for role of viruses in cancer

Post Your Comments:

(Date:11/25/2009)...may be used to boost resistance to, or slow, the d...Medicine researchers report in a study published i... , Parkinson,s disease is caused by a degenerati...known as the substantia nigra, which is responsibl...dopamine in late-stage Parkinson,s causes symptoms...

(Date:11/25/2009)...ps some 250 million liters of blood through the bo...the heart have to be extremely durable. The resear...air of the Department of Medicine III at Heidelber...atus), has discovered a protein that is responsibl... the sarcomere. In cooperation with other research...

(Date:11/24/2009)...standing how sounds associated with Navy sonar mig...ey hear it at all. , The same type of large indu...ct flaws in the space shuttle,s behemoth solid fue...e the giant head of a whale. The scans are providi...s hearing anatomy using a breakthrough method deve...

Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2 New genetic cause of cardiac failure discovered 2 Rocket science leads to new whale discovery 2 Global Med Technologies 28R 29 Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 14225 1 Global Med Technologies 28R 29 Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 14225 2 Global Med Technologies 28R 29 Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 14225 3 Global Med Technologies 28R 29 Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 14225 4 Global Med Technologies 28R 29 Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 14225 5 Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer 5034 1 Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer 5034 2 Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer 5034 3 Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer 5034 4 Study reveals 2 3 of prostate cancer patients do not need treatment 58130 1 Study reveals 2 3 of prostate cancer patients do not need treatment 58130 2

[1] Hormone ghrelin can boost resistance to Parkinson's disease [1] New genetic cause of cardiac failure discovered [1] Rocket science leads to new whale discovery

(Date:11/24/2009)...employment grew by 29,000 jobs in October, and th...owth during the U.S. recession. However, clinics a...th systems are coming closer to having to actually...tors. , (Vocus) November ...ng in October despite the shedding of jobs in most...

(Date:11/24/2009)...re-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abiop...alizingnovelpainmanagementtherapies,announcedtoday...er,isscheduledtopresentatthe21stAnnualPiperJaffray...NewYorkPalaceHotelinNewYork,NewYork. ,, Mr.DiTo...eavailabletorespondtoquestionsduringthepresentatio...

(Date:11/24/2009)...tly approved the Promega PowerPlex 16 HS System fo...ng DNA records for the National DNA Index System. ... -- The FBI recently approved the Promega PowerPl...icipating in, or generating DNA records for, the N...ntains more than seven million profiles and has as...

(Date:11/24/2009)...rstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglo...edthatithassubmittedaMAAtotheEuropeanMedicinesAgen...enttherapyindevelopment,forthetreatmentofType1Gauc...elaglucerasealfathathasbeensubmitted,withprevious,...donaglobalsupplyshortageofthecurrentlyapprovedandm...

Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2 The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3 The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4 NeurogesX to Present at Piper Jaffray Health Care Conference 2 NeurogesX to Present at Piper Jaffray Health Care Conference 3 NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2 Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2 Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3

[0] The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close [0] NeurogesX to Present at Piper Jaffray Health Care Conference [0] NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database [0] Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease

Other News:

...may be facing some changes due to the recent work ...ity in St. Louis. And that may change our underst...on earth. ...Carrine Blank, Ph.D. , assistant prof...iences, has found that the currently accepted date...

...erlands Cancer Institute in Amsterdam have discove...lls. Together with colleagues from the University ...arten van Lohuizen published their findings on 18 ...d stem cells can both reproduce themselves in unli...

...dge, MA, April 13, 2004 - MacroPore Biosurgery, In...today announced pre-clinical findings that suggest...ive cells have the potential to engraft injured my...rentiation into cardiac myocytes. These results pr...

...n University in St. Louis has co-authored a new bo...utside the helmet." ......... Jonathan M. Cha...ashington University and Mathew A. Leibold, Ph.D.,...he University of Texas at Austin, are the authors ...

Biologist's find alters the bacteria family tree 2 Biologist's find alters the bacteria family tree 3 Biologist's find alters the bacteria family tree 4 Gene plays major role in formation of stem cells and cancer 2 MacroPore - adipose-derived cells - potential to engraft & differentiate into heart muscle 2 New book urges ecologists to think 'outside the helmet' 2

Biologist's find alters the bacteria family tree Gene plays major role in formation of stem cells and cancer MacroPore - adipose-derived cells - potential to engraft & differentiate into heart muscle New book urges ecologists to think 'outside the helmet'

...enneth M. Quinn, President of the World Food Prize...an government official Monday, July 10 at the Open...ience in Philadelphia for what Nobel Peace Prize L...he great achievements of agricultural science in t...

...g Ceremony of the 18th World Congress of Soil Scie...Sciences (IUSS), the Soil Science Society of Ameri...l Science.......WHEN--Monday, July 10. Introductor...ring Jeffrey Sachs begins at 9:15 a.m.......WHO--C...

...ted that the 47 countries and 34 international org... secured the future of this young organisation, an... Chair of the GBIF Governing Board. "We look forw...ew phase."...GBIF will continue to work to make bi...

..., Madagascar (June 24, 2006) Ambitious goals for ...able without radical changes that make biodiversit...evelopment policies, a global environmental confer...zed by Conservation International, titled "Defying...

2006 World Food Prize recipients to be recognized at soils congress 2 The End of Poverty author to keynote soils congress 2 New phase for Global Biodiversity Information Facility 2 New phase for Global Biodiversity Information Facility 3 'Madagascar Declaration' focuses African development policies on value of nature 2 'Madagascar Declaration' focuses African development policies on value of nature 3

2006 World Food Prize recipients to be recognized at soils congress The End of Poverty author to keynote soils congress New phase for Global Biodiversity Information Facility 'Madagascar Declaration' focuses African development policies on value of nature